Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01292538 · ClinicalTrials.gov registry record · NA
Study of the Effectiveness of Green Diode Laser Light on Body Shaping
A NA study of Body Contouring, sponsored by Erchonia Corporation.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
- 2
- Study locations
NCT01292538: Completed NA study of Body Contouring, sponsored by Erchonia Corporation.
NCT01292538 is a NA study of Body Contouring that has completed, run by Erchonia Corporation. The registered enrollment target is 67 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01292538, a NA study of Body Contouring, has completed, sponsored by Erchonia Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine if 532nm green diode laser light is effective in body contouring of the waist, hips and thighs.
Primary Outcome
Mean change in total combined circumference inches of the waist, hips and bilateral thighs from baseline to endpoint evaluation.
Conditions Studied
Interventions
- DEVICE Erchonia GLS
- DEVICE Placebo laser
Study Locations (2)
Indiana
- Surgeon's Inc. - Marion
Michigan
- Bloomfield Laser and Cosmetic Surgery Center - Bloomfield Hills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2011-02 |
| Est. Completion | 2012-06 |
| Phase | NA |
What the finished NCT01292538 record still lists
NCT01292538 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Body Contouring appearing as the primary indexed condition, and to 2 interventions - of which Erchonia GLS is the first listed.
NCT01292538 reports a single indexed study location in Indiana, Michigan.
Frequently Asked Questions
What is clinical trial NCT01292538 about?
NCT01292538 is a clinical study titled "Study of the Effectiveness of Green Diode Laser Light on Body Shaping". The purpose of this study is to determine if 532nm green diode laser light is effective in body contouring of the waist, hips and thighs.
What is the current status of trial NCT01292538?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2011-02. Estimated completion is 2012-06.
What conditions does trial NCT01292538 study?
This clinical trial studies the following conditions: Body Contouring.
What interventions are being tested in trial NCT01292538?
The interventions under investigation include: Erchonia GLS (DEVICE), Placebo laser (DEVICE).
Who is sponsoring clinical trial NCT01292538?
This trial is sponsored by Erchonia Corporation, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01292538 being conducted?
This trial has 2 study locations across Indiana, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Body Contouring
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01292538's enrollment target sits among peer trials
67 1139th of 2000 higher than 862 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia